Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

HealthLynked (HLYK) Revenue (2016 - 2025)

HealthLynked (HLYK) has disclosed Revenue for 10 consecutive years, with $388545.0 as the latest value for Q3 2025.

  • On a quarterly basis, Revenue fell 34.16% to $388545.0 in Q3 2025 year-over-year; TTM through Sep 2025 was $2.4 million, a 28.51% decrease, with the full-year FY2024 number at $3.0 million, down 47.43% from a year prior.
  • Revenue was $388545.0 for Q3 2025 at HealthLynked, down from $592360.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $4.6 million in Q3 2021 to a low of -$1.8 million in Q4 2021.
  • A 5-year average of $1.1 million and a median of $1.0 million in 2024 define the central range for Revenue.
  • Peak YoY movement for Revenue: plummeted 965.4% in 2021, then surged 746.56% in 2023.
  • HealthLynked's Revenue stood at -$1.8 million in 2021, then skyrocketed by 106.19% to $110000.0 in 2022, then surged by 746.56% to $931214.0 in 2023, then tumbled by 33.54% to $618927.0 in 2024, then crashed by 37.22% to $388545.0 in 2025.
  • Per Business Quant, the three most recent readings for HLYK's Revenue are $388545.0 (Q3 2025), $592360.0 (Q2 2025), and $774208.0 (Q1 2025).